Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)

NCT06513065 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Pseudomyxoma Peritonei

Interventions

DRUG: Mitomycin c

Sponsor

University of Southampton